Jyong Biotech Ltd. cotiza a 2.10 USD y tiene una capitalización bursátil de $160M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Jyong Biotech Ltd., a science-driven biotechnology company, engages in the development and commercialization of plant-derived drugs for the treatment of urinary system diseases in the United States, the European Union, and Asia. It develops Botreso, for the treatment of benign prostate hyperplasia/lower urinary tract s…
| Métrica | MENS | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | — | -40.4% | — |
| ROA | -22.5% | -32.0% | +9.5% |
| Current Ratio | 0.45 | 2.84 | -2.39 |
| Debt / Equity | -0.09 | 0.28 | -0.37 |